Coordinated augmentation of NFAT and NOD signaling mediates proliferative VSMC phenotype switch under hyperinsulinemia
- PMID: 26814423
- DOI: 10.1016/j.atherosclerosis.2016.01.006
Coordinated augmentation of NFAT and NOD signaling mediates proliferative VSMC phenotype switch under hyperinsulinemia
Abstract
Aim: Although hyperglycemia has been demonstrated to play a significant role in the vascular disease associated with type 2 diabetes, the mechanisms underlying hyperinsulinemia mediated vascular dysfunction are not well understood. We have analyzed whether hyperinsulinemia could activate NFAT (Nuclear factor of activated T cells) signaling and thereby influence vascular smooth muscle cell (VSMC) migration and proliferation, a major event in the progression of atherosclerosis.
Methods and results: Human aortic VSMCs upon chronic insulin treatment exhibited increased expression of NFATc1 both at the mRNA and protein levels. The mechanistic role of NFAT in VSMC migration and proliferation was examined using 11R-VIVIT, a cell permeable NFAT specific inhibitor, where it reduced the insulin effect on VSMC, which was further substantiated by over expression or silencing of NFATc1gene (p < 0.05). This study also report for the first time the role of NFAT in NOD (Nucleotide oligomerization domain) mediated innate immune signaling and its significance in insulin effect on VSMCs. mRNA expression of NOD was up regulated when cells were treated with insulin or ligands whereas pretreatment with 11R-VIVIT reversed this effect (p < 0.05). Our study uphold the clinical significance as we observed an increased mRNA expression of NFATc1 in monocytes isolated from patients with type 2 diabetes which correlated positively with insulin resistance and glycemic load (p < 0.05).
Discussion: This study suggests that targeted NFAT inhibition can be an effective strategy to coordinately quench insulin induced proliferative and inflammatory responses along with innate immunity alterations in vascular smooth muscle cells, which underlie atherosclerosis.
Keywords: Atherosclerosis; Diabetes; Innate immunity; NFAT; Vascular smooth muscle cells.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.Arterioscler Thromb Vasc Biol. 2016 May;36(5):864-73. doi: 10.1161/ATVBAHA.115.306770. Epub 2016 Mar 3. Arterioscler Thromb Vasc Biol. 2016. PMID: 26941017 Free PMC article.
-
Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent.Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1531-7. doi: 10.1161/01.ATV.0000225286.30710.af. Epub 2006 May 4. Arterioscler Thromb Vasc Biol. 2006. PMID: 16675727
-
Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.Cardiovasc Diabetol. 2016 Dec 1;15(1):161. doi: 10.1186/s12933-016-0477-3. Cardiovasc Diabetol. 2016. PMID: 27905925 Free PMC article.
-
Influence of glucose metabolism on vascular smooth muscle cell proliferation.Vasa. 2013 Jan;42(1):8-16. doi: 10.1024/0301-1526/a000243. Vasa. 2013. PMID: 23385222 Review.
-
Six Shades of Vascular Smooth Muscle Cells Illuminated by KLF4 (Krüppel-Like Factor 4).Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2693-2707. doi: 10.1161/ATVBAHA.121.316600. Epub 2021 Sep 2. Arterioscler Thromb Vasc Biol. 2021. PMID: 34470477 Free PMC article. Review.
Cited by
-
CD137-CD137L interaction modulates neointima formation and the phenotype transformation of vascular smooth muscle cells via NFATc1 signaling.Mol Cell Biochem. 2018 Feb;439(1-2):65-74. doi: 10.1007/s11010-017-3136-4. Epub 2017 Aug 2. Mol Cell Biochem. 2018. PMID: 28770466
-
Innate Immune Receptors, Key Actors in Cardiovascular Diseases.JACC Basic Transl Sci. 2020 Jul 27;5(7):735-749. doi: 10.1016/j.jacbts.2020.03.015. eCollection 2020 Jul. JACC Basic Transl Sci. 2020. PMID: 32760860 Free PMC article. Review.
-
Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis.Basic Res Cardiol. 2020 Jun 25;115(4):47. doi: 10.1007/s00395-020-0806-2. Basic Res Cardiol. 2020. PMID: 32588196 Free PMC article.
-
Developmental endothelial locus 1: the present and future of an endogenous factor in vessels.Front Physiol. 2024 Aug 9;15:1347888. doi: 10.3389/fphys.2024.1347888. eCollection 2024. Front Physiol. 2024. PMID: 39206385 Free PMC article. Review.
-
KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.Int J Mol Med. 2018 Mar;41(3):1265-1274. doi: 10.3892/ijmm.2017.3351. Epub 2017 Dec 29. Int J Mol Med. 2018. PMID: 29286083 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous